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The interaction between bacteria and fibronectin is believed to play an important role in the pathogenicity of clinically impor-
tant Gram-positive cocci. In the present study, we identified a gene encoding a predicted fibronectin-binding protein of Entero-
coccus faecium (fnm), a homologue of Streptococcus pneumoniae pavA, in the genomes of E. faecium strain TX82 and all other
sequenced E. faecium isolates. Full-length recombinant Fnm from strain TX82 bound to immobilized fibronectin in a concen-
tration-dependent manner and also appeared to bind collagen type V and laminin, but not other proteins, such as transferrin,
heparin, bovine serum albumin, mucin, or collagen IV.We demonstrated that the N-terminal fragment of Fnm is required for
full fibronectin binding, since truncation of this region caused a 2.4-fold decrease (P< 0.05) in the adhesion of E. faecium TX82
to fibronectin. Deletion of fnm resulted in a significant reduction (P< 0.001) in the ability of the mutant, TX6128, to bind fi-
bronectin relative to that of the wild-type strain; in situ reconstitution of fnm in the deletion mutant strain restored adherence.
In addition, thefnmmutant was highly attenuated relative to TX82 (P< 0.0001) in a mixed-inoculum rat endocarditis model.
Taken together, these results demonstrate that Fnm affects the adherence of E. faecium to fibronectin and is important in the
pathogenesis of experimental endocarditis.
Bacterial adherence to host tissues and extracellular matrix(ECM) proteins is a critical step in the process of infection,
since it establishes the initial contact with the host. These interac-
tions can facilitate translocation across the mucosal barrier and
internalization into subcellular compartments, eventually leading
to bacterial spread within eukaryotic cells (1). Particularly in
Gram-positive pathogens, surface-exposed adherence molecules,
such asMSCRAMMs (microbial surface components recognizing
adhesivematrixmolecules), are key players in host-microbe inter-
actions (2). Host ligands include ECM components, e.g., fi-
bronectin, collagen, and laminin, as well as molecules that are also
present in blood, including fibrinogen and vitronectin (2).
Generally reported as a well-adapted commensal of the gastro-
intestinal tracts of humans and animals, Enterococcus faecium has
emerged over the past 3 decades as a leading cause of hospital-
associated diseases, including urinary tract infections (UTIs), bac-
teremia, intra-abdominal infections, and endocarditis (3–5). The
rising incidence of multiantibiotic-resistant nosocomial infec-
tions caused by E. faecium has led to the inclusion of these organ-
isms in the list of “no ESKAPE” (E. faecium, Staphylococcus aureus,
Klebsiella, Acinetobacter, Pseudomonas, and Enterobacteriaceae)
pathogens that pose a challenge to clinicians and threaten patient
safety (6). In the United States, approximately 80% of health care-
associatedE. faecium strains are vancomycin-resistant enterococci
(VRE), and more than 90% are ampicillin resistant (5). The fre-
quent lack of an antibiotic regimen of proven efficacy has sparked
an interest in understanding the molecular mechanisms that con-
tribute to E. faecium pathogenesis.
Fibronectin (Fn) is a large multidomain dimeric glycoprotein
found in body fluids and in the ECM (7). Targeting of Fn by
several pathogens has been shown to be important in the estab-
lishment or dissemination of infection (8). Bacterial Fn-binding
proteins were first discovered in Staphylococcus aureus, followed
by Streptococcus pyogenes and many other Gram-positive and
Gram-negative microbes (9–11). The majority of reported strep-
tococcal and staphylococcal Fn-binding proteins are character-
ized by the presence of an N-terminal signal sequence, which is
needed for export of the protein to the cell surface via Sec-depen-
dent secretion, and an LPXTG motif at the C-terminal end for
covalent anchoring to peptidoglycan. These proteins also possess
specific signature repeat motifs (35 to 40 residues) in the C termi-
nus, whichmediate Fn binding (12, 13). Streptococcus pneumoniae
also expresses another type of adhesin, known as the pneumococ-
cal adherence and virulence factor A (PavA) protein (14), that
lacks the above-mentioned features of prototypic Fn-binding pro-
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teins (15, 16). Nonetheless, PavA has been shown to be present on
the surfaces of S. pneumoniae cells and to bind to immobilized Fn
(14). Notably, isogenic pavA deletionmutants showed highly (ap-
proximately 104-fold) attenuated virulence in a mouse sepsis
model, suggesting a direct role for PavA in pneumococcal patho-
genesis (14). Attenuation of the virulence of PavA-deficient pneu-
mococcal strains was also observed in a mouse meningitis model,
and these strains also showed substantially reduced adherence to
and internalization by epithelial cell lines (17). These results are
consistent with the finding that PavA is important for the ability of
pneumococci to escape phagocytosis and to induce adaptive im-
mune responses (18). In addition, Kadioglu and colleagues dem-
onstrated that PavA is required for successful colonization and
long-term carriage on the murine nasopharynx and for the sys-
temic spread of pneumococci (19).
PavA homologues have been identified in other streptococci;
these include Streptococcus gordonii FbpA (20), Streptococcus pyo-
genes FBP54 (21, 22), and Streptococcus mutans SmFnB (23). A
similar report showed that SfbA, a PavA homologue of group B
streptococci, is important in the interaction of these bacteria with
the blood-brain barrier endothelium and in the pathogenesis of
neonatal meningitis (24). Recently, Torelli et al. identified EfbA, a
PavA homologue in Enterococcus faecalis, and demonstrated that
the derived recombinant protein binds to immobilized Fn and
plays a role in the pathogenesis of UTIs (25).
The present work was initiated to identify and study the PavA
homologue of E. faecium and its contribution to Fn adherence in
the context of infection. Here we show that Fnm, encoded by the
E. faecium homologue of S. pneumoniae pavA, is an Fn-binding
protein. In addition, we evaluated the effect of the fnm deletion on
the ability of E. faecium TX82 to bind to Fn, and we demonstrate
that Fnm is important in the pathogenesis of experimental endo-
carditis.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The strains and plasmids used
in this study are listed in Table 1. Enterococci were routinely grown at
37°C in brain heart infusion (BHI) broth and agar, or inM17 broth (both
from Difco Laboratories), unless otherwise indicated. Escherichia coli
strains were cultured at 37°C in Luria-Bertani (LB) broth and agar (Difco
Laboratories). The following antibiotic concentrations were used for en-
terococci: ampicillin, 32g/ml; erythromycin, 10g/ml; gentamicin, 200
g/ml. For E. coli, the concentrations used were 100g/ml ampicillin and
25 g/ml gentamicin.
DNA techniques. E. faecium genomic DNAwas isolated from a single
colony after overnight growth in BHI broth, as described previously (26).
Plasmids were isolated from E. coli using Wizard Plus SV MiniPreps sys-
tem columns (Promega Corporation). Phusion DNA polymerase (New
EnglandBioLabs,UnitedKingdom)was employed for PCRamplification.
Primers were purchased from Sigma-Aldrich (see Table S1 in the supple-
mental material). DNA fragments were purified by agarose gel electro-
phoresis and Wizard SV Gel and PCR Clean-Up system columns (Pro-
mega Corporation). Restriction endonucleases and T4 DNA ligase (both
fromNewEnglandBioLabs, UnitedKingdom)were used according to the
manufacturer’s recommendations. TheDNA sequencing service was pro-
vided by Genewiz Inc., South Plainfield, NJ, USA.
Construction of an fnm deletionmutant and reconstitution of fnm.
Mutants were generated using pHOU1, a pheS*-based counterselection
system, as described previously (27). Briefly, to construct an fnm deletion
mutant of E. faecium TX82, the upstream DNA region flanking the fnm
gene (672 bp) together with the initial 147 bp of the Fnm-encoding
region and the 903-bp downstream flanking sequence were amplified by
two independent PCRs using primer pairs fnmUpF/fnmUpR and
fnmDownF/fnmDownR, respectively (see Table S1 in the supplemental
material). The two fragments were then fused by SOE-PCR (splicing by
overlap extension PCR). The resulting 1,722-bp product was digested
with restriction enzymes BamHI and SphI and was cloned into similarly
digested pHOU1 (27), giving pTX6128. pTX6128 was electroporated into
E. coli EC1000, which supplies RepA in trans for its replication (28).
Transformants were screened for the presence of the insert, and the frag-
ment was sequenced using the primer pair FbpOutF/FbpOutR (see Table
S1). pTX6128 was electroporated into E. faecalis CK111 using standard
procedures (29, 30) before transfer to E. faecium TX82 by filter matings.
The mating mixture was cultivated on BHI plates containing gentamicin
and erythromycin for the detection of single-crossover integrants andwas
then replated onto MM9–yeast extract–glucose (MM9YEG) medium
containing p-chloro-phenylalanine (p-Cl-Phe) (7mM) to select for vector
TABLE 1 Bacterial strains used in this study
Strain or plasmid Descriptiona Source or reference
Strains
E. coli
DH5 General cloning host Stratagene
EC1000 Strain carrying the repA gene for replication of pHOU1 28
BL21(DE3) Strain for recombinant protein expression Life Technologies
E. faecium
TX82 Nosocomial isolate (endocarditis); Ampr Vanr Ermr 59
TX6128 TX82fnm; an fnm markerless deletion mutant This study
TX6155 TX82fnm::fnm; a derivative of TX6128 with fnm restored in situ in the chromosome This study
E. faecalis CK111 Conjugative donor; provides repA in trans for pHOU1 replication 29
Plasmids
pHOU1 Vector for allelic exchange in E. faecium; carries the p-chloro-phenylalanine counterselectable marker; Genr 27
pTX6128 pHOU1 derivative carrying a 1,719-bp BamHI/SphI fragment for deletion of fnm This study
pTX6155 Vector for reconstitution of fnm containing a 3,180-bp fragment cloned into pHOU1 This study
pET19b Vector for protein overexpression in E. coli containing an N-terminal histidine-tagged fusion; Ampr This study
pETFnm01 pET19b derivative carrying the construct for full-length Fnm protein overexpression; Ampr This study
pETFnm02 pET19b derivative carrying the construct for overexpression of Fnm1-295; Amp
r This study
pETFnm03 pET19b derivative carrying the construct for overexpression of Fnm1-414; Amp
r This study
pETFnm04 pET19b derivative carrying the construct for overexpression of Fnm416-535; Amp
r This study
a Ampr, ampicillin resistant; Ermr, erythromycin resistant; Genr, gentamicin resistant; Vanr, vancomycin resistant.
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excision. The excision of pTX6128 was confirmed by the absence of
growth on BHI-gentamicin plates; colonies lacking fnm were detected by
PCR, and one of these was designated TX6128.
For the restoration of fnm in TX6128, the fnm gene with its native
promoter was amplified by PCR with primer pair fnmUpF/fnmDownR
(see Table S1 in the supplemental material). Following digestion with
BamHI and SphI, the resulting 3,180-bp fragment was cloned into
pHOU1, giving pTX6155, which, after confirmation of the insert by se-
quencing, was electroporated into E. faecalis CK111, transferred to E.
faecium TX6128, and then processed as described above. The resulting
fnm-reconstituted strain was named TX6155.
The deletion and restoration of the fnm gene in TX6128 and TX6155,
respectively, were confirmed by sequencing of the PCR product amplified
with primer pair FbpOutF/FbpOutR. In addition, the identities of the
strains were confirmed by pulsed-field gel electrophoresis according to a
method described previously (31).
Whole-cell fibronectin binding assays. E. faecium TX82, TX6128,
and TX6155 cells were harvested by centrifugation from exponential-
phase cultures in BHI medium supplemented with 40% serum (BHIS),
and the concentration was adjusted to an optical density (OD) at 600 nm
of 1.0 in phosphate-buffered saline (PBS; pH 7.4). Immulon 2Bmicrowell
plates (Thermo Scientific, Woburn, MA) were coated overnight with 20
g/ml of Fn. Bovine serum albumin (BSA) was used as a negative control.
Wells were blocked with 2% BSA at room temperature (RT) for 1 h, and
after three washes with PBS, a 100-l volume of a cell suspension was
added. Plates were incubated for 2 h at RT. After three washes with PBS to
remove unbound cells, cells were fixed with Bouin’s fixative solution (Sig-
ma-Aldrich Co., St. Louis, MO) for 30 min at RT. Each well was then
washed with PBS and was stained with 1% (wt/vol) crystal violet for 30
min at RT. Finally, adherent cells were dissolved in an ethanol-acetone
solution (80% and 20%, respectively), and the absorbance at 570 nm was
measured using a microplate reader (Thermo Scientific, Waltham, MA).
Experiments were performed 3 times using 8 technical replicates each
time. The adherence of TX6128 and TX6155 to Fn was expressed as the
percentage of binding relative to the binding of Enterococcus faecalis
OG1RF (defined as 100%).
Expression and purification of Fnm and its truncated derivatives.
DNA regions corresponding to full-length Fnm or to its truncated deriv-
ative Fnm1–295, Fnm1–414, or Fnm416–535 were amplified from TX82
genomicDNAusing specific primers (listed in Table S1 in the supplemen-
tal material), which introduced NdeI and BamHI restriction sites. The
fragmentswere cloned in frame into plasmid pET19b, and the overexpres-
sion constructs were transformed into E. coli BL21(DE3). Cultures were
grown to exponential phase, and protein expression was induced with 0.5
mM IPTG (isopropyl--D-thiogalactopyranoside) for 3 h at 37°C. Histi-
dine-tagged recombinant Fnm (rFnm) and its derivativeswere purified by
Ni-nitrilotriacetic acid (NTA) chromatography using His GraviTrap col-
umns (GE Healthcare) according to the manufacturer’s instructions. The
eluted proteins were desalted using PD-10 desalting columns (GEHealth-
care). The protein concentration of each sample was determined by the
bicinchoninic acid (BCA) method (Pierce). Recombinant proteins were
stored at70°C until use.
Generation of polyclonal antibodies and purification of antigen-
specific IgGs. Polyclonal rabbit antibodies against rFnm were raised at
Bethyl Laboratories (Montgomery, TX, USA), and rFnm-specific anti-
bodies were purified using CnBr-Sepharose 4B coupled with rFnm as
described elsewhere (32). Eluted antibodies were neutralized immediately
using 0.1 M Tris (pH 8.0) and were dialyzed extensively against PBS, and
concentrations were determined using an IgG molar absorption coeffi-
cient value of 210,000 M1 cm1 and a molecular mass of 150,000 Da.
Enzyme-linked immunosorbent assay (ELISA).Thebindingof rFnm
to ECM proteins was measured as described previously (33). Medium
binding Immulon 2Bmicrowell plates (Thermo Scientific,Woburn,MA)
were coated with ECM proteins (1 g/100 l) dissolved in 50 mM car-
bonate buffer and were incubated overnight at 4°C. Wells were blocked
with 2%BSA atRT for 1 h andwere thenwashedwith PBS, followed by the
addition of various concentrations of recombinant proteins. After incu-
bation for 2 h at RT, plates were washed three times with PBS-T (PBSwith
0.05% Tween 20), and the binding of full-length rFnm and truncated
versions to ECM was detected by incubation with anti-His monoclonal
antibodies (GE Healthcare) and alkaline phosphatase-conjugated anti-
mouse IgG antibodies (Jackson ImmunoResearch Laboratories); p-nitro-
phenyl phosphate (Sigma) was used for signal detection. The absorbance
at 405 nm was then determined with a microplate reader (Thermo Scien-
tific, Waltham, MA).
Extraction of CWA proteins with mutanolysin and immunoblot
analysis. E. faecium strains were grown for 5 h or 16 h in BHI or BHIS
broth, and cell wall-anchored (CWA) proteins were extracted with muta-
nolysin as described previously (34). After measurement of the protein
concentrations by the BCA method (Pierce), equal amounts of mutano-
lysin-extracted proteins were resolved using SDS-PAGE gels under reduc-
ing conditions, and the proteins were transferred to nitrocellulose mem-
branes. After blocking with 2% skim milk in PBS for 1 h, the membrane
was probed with affinity-purified anti-rFnm antibodies, followed by
horseradish peroxidase (HRP)-conjugated anti-goat IgG antibodies, and
the signal was detected by using the SuperSignal West Pico chemilumi-
nescent reagent (Thermo Scientific).
Experimental endocarditis and urinary tract infection (UTI) mod-
els. The animal experimental procedures were carried out in accordance
with the institutional policies stipulated by the Animal Welfare Commit-
tee, University of Texas Health Science Center at Houston. Aortic valve
endocarditis was induced in white Sprague-Dawley rats according to a
method published previously (35). Briefly, catheterized rats were inocu-
lated intravenously, via the tail vein, with a mixture of TX82 and TX6128
(at a1:1 ratio, determined by absorbance at 600 nm) 24 h after catheter
placement. The inocula were then serially diluted and were plated to de-
termine the actual CFU and percentage of each strain. At 48 h postinfec-
tion, animals were euthanized, hearts were aseptically removed, and the
aortic valves were excised, weighed, and homogenized in 1 ml of saline
solution. Serial dilutions were plated onto Enterococcosel Agar (EA)
(Difco Laboratories) supplemented with 6 g/ml vancomycin. Colonies
were randomly picked into wells of 96-well microtiter plates containing
BHI broth, grown overnight, replica plated onto BHI agar, and trans-
ferred to a filter overlaid on the BHI plate. The colonies were then lysed in
situ, and the filters were hybridized under high-stringency conditions
(36), using intragenic DNA probes of fnm and ddl (37) to calculate the
percentages of wild-type and mutant colonies recovered from aortic
valves.
For UTI infection experiments, 4- to 6-week-old female ICR mice
(Harlan Laboratories) were used. The experiments were conducted ac-
cording to the methodology previously adopted by Singh et al. (38).
Statistical analysis. Statistical comparisons were performed with a
paired Student t test by using GraphPad Prism, version 4.00 forWindows
(GraphPad Software, SanDiego, CA). Differences were considered signif-
icant at a P value of0.05.
RESULTS
Genetic organization ofE. faeciumTX82 fnm.Using the S. pneu-
moniae PavA sequence as the query for tBLASTn searches, we
identified a homologous gene in the genome of E. faecium TX82.
This gene was also found in all currently available E. faecium ge-
nome sequences (data not shown). Figure 1 depicts the genomic
organization of the pavA homologue in TX82 (HMPREF9522_
00874). It is 1,707 bp long and is flanked upstream by genes en-
coding a putative transposase and ABC transporters and down-
stream by a gene coding for a LysR-like transcriptional regulator.
The putative protein consists of 568 amino acids (aa) and contains
an N-terminal region identified by InterPro (http://www.ebi.ac
.uk/interpro/) as a homologue of theN terminus (PF05833; aa 4 to
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431) of S. gordonii fibronectin-binding protein A (FbpA), fol-
lowed by a domain of unknown function (Duf814; aa 451 to 535)
(Fig. 1, expanded segment). Based on the predicted function, we
designated this protein Fnm (fibronectin-binding protein of En-
terococcus faecium). As with other reported PavA-like proteins,
Fnm lacks an N-terminal signal sequence for exporting the pro-
tein and the typical Gram-positive LPXTG cell wall anchor motif
at the C terminus (14). This protein shares 52% identity and 70%
similarity with S. pneumoniaePavA (Fig. 2). In addition, Fnm is 49
to 70% identical and 68 to 84% similar to E. faecalis EfbA (25), S.
pyogenes FBP54 (39), S. gordonii FnBpA (20), group B streptococ-
cus SfbA (24), and S. mutans SmFnB (23) (Fig. 2).
The recombinant E. faecium Fnm protein binds to Fn and
other components of the ECM.To determine if Fnmhas the abil-
ity to bind to Fn, we expressed full-length Fnm as a histidine-
tagged fusion protein in E. coli and purified it by Ni-NTA chro-
matography. The recombinant Fnm showed concentration-
dependent binding to immobilized Fn, and this binding appeared
to be saturated at concentrations of added rFnm above 5 pM (Fig.
3A). Significant amounts of rFnm also bound to laminin and type
V collagen, and intermediate levels of rFnm binding to wells
coated with fibrinogen, collagen I, or heparan sulfate were seen
(Fig. 3B). Little to no binding to transferrin, BSA, heparin, hyal-
uronic acid, mucin, or collagen IV was observed (Fig. 3B).
In order to investigate the functional domains of the protein
required for Fn binding, truncated versions of rFnm (comprising
aa 1 to 295, aa 1 to 414, or aa 416 to 535) were generated in E. coli,
purified, and tested for their abilities to bind to Fn (Fig. 4A). The
truncated proteins rFnm1–295, containing part of the in silico-des-
ignated N-terminal Fn-binding domain, and rFnm414–535, corre-
FIG1 Diagramof the genetic organization and domainmapping ofEnterococcus faeciumTX82 Fnm.The fnm locus is flanked upstreamby transposase- andABC
transporter-encoding genes and downstream by a gene coding for a LysR-like transcriptional regulator. The expanded segment shows the domain organization
of Fnm. The annotated FbpA homologue domain spans the region from amino acid 4 to 431; the Duf814 domain (a domain of unknown function; aa 451 to 535)
is commonly found in association with the FbpA domain.
FIG2 Alignment of the amino acid sequence of E. faeciumTX82 Fnmwith those of other reported PavA homologue proteins: E. faecalisEfbA, S. pyogenes FBP54,
S. pneumoniae PavA, S. gordonii FnBpA, group B streptococcus SfbA, S. mutans SmFnB. Residue conservation is indicated by shades of blue. Highly conserved
sequences are shown in dark blue; a low degree of consensus is indicated in light blue. The red and green lines under the residues indicate the FbpA and Duf814
domains, respectively. The alignment was generated using the MUSCLE program, by applying the default settings.
Somarajan et al.
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sponding to the C-terminal Duf814 domain only, showed signif-
icantly less (P  0.05) binding to Fn than did full-length rFnm
(Fig. 4B), although some binding remained. However, a protein
containing the extended N-terminal FbpA domain (aa 1 to 414)
bound to Fn at levels similar to those of full-length rFnm. These
data demonstrate that the N-terminal domain alone is sufficient
for wild-type-level Fn binding. This finding differs from earlier
reports on S. pneumoniae PavA, where the C-terminally truncated
proteins showed no binding to Fn (14).
To confirm the role of Fnm in the binding of E. faecium TX82
cells to Fn, we constructed an in-frame markerless fnm mutant
(TX6128) and a knocked-in (reconstituted) strain in which the
gene was restored in its native site in the chromosome of the fnm
deletionmutant (TX6155). TX6128 andTX6155 exhibited growth
rates similar to that of TX82 in BHIS at 37°C (data not shown). In
subsequent assays of whole-cell binding to immobilized Fn, the
deletion mutant displayed a level of binding 29% lower (P 
0.001) than that of TX82 (Fig. 5). The remaining ability of the
deletionmutant to bind Fn could be attributed to the redundancy
of fibronectin-binding proteins in E. faecium, including the WxL
domain-containing proteins SwpA-C, LwpA-C, and DufA-C
(26). Reconstitution of fnm in TX6155 restored thewild-type phe-
notype.
Fnm is expressed on the surfaces of Enterococcus faecium
cells.Next, we examinedwhether Fnm is expressed on the surfaces
of E. faecium cells. For this purpose, we generated cell wall extracts
by mutanolysin digestion of TX82, TX6128, and TX6155 cells.
Since serum has been shown to act as a biological cue that elicits
adherence to the extracellular matrix proteins of some other bac-
teria (40),E. faecium cells were grown inBHI broth in the presence
or absence of horse serum at 37°C, and samples were collected at
the exponential and stationary phases of growth. Immunoblotting
using anti-Fnm specific antibodies showed that Fnm was found
only in the cell wall extracts of the wild-type strain TX82 and the
fnm-reconstituted strain TX6155; it was not detected in the cell
wall extract of the deletionmutant TX6128 (Fig. 6). In addition, it
was evident that Fnm expression was increased in the presence of
40% horse serum and that expression levels were higher in the
stationary phase than in the exponential phase of growth (Fig. 6).
No Fnm expression was detectable in the absence of serum, sug-
gesting the possibility that stressful conditions may regulate the
expression of Fnm protein in vivo.
Fnm contributes to the pathogenesis of infective endocardi-
tis in vivo. Next, to determine whether a lack of Fnm translates
into a reduced ability to cause infection, we used an established
model of E. faecium endocarditis to test the fnm deletion mutant
TX6128. For this purpose, catheterized rats were injected intrave-
FIG 3 Binding of full-length rFnm to immobilized ECM components as detected by ELISA. (A) Concentration-dependent binding of rFnm to fibronectin. (B)
Binding of rFnm to other immobilized ECM components. ELISA plates were coated with ECM proteins (1 g/well), which were incubated with various
concentrations of rFnm. The binding of rFnm to ECM proteins was detected using anti-His tag antibodies. Data represent means	 standard deviations.
FIG 4 (A) Domain structures of truncated rFnm polypeptides. (B) Binding of
truncated rFnm polypeptides to immobilized fibronectin as detected by
ELISA. Equimolar concentrations of full-length rFnm or truncated versions of
rFnm were tested for reactivity to immobilized fibronectin (1 g/well).
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nously, through the tail vein, with a mixture of TX82 and TX6128
as an inoculum. CFU determination showed that the mixed inoc-
ulum administered consisted of 47% wild-type cells (2.9 
 109
CFU) and 53% (3.4 
 109 CFU) fnm deletion mutant cells. As
shown in Fig. 7, TX6128 was significantly attenuated relative to
the wild-type strain, TX82 (P,0.0001 by a paired Student t test).
This suggests a clear advantage of TX82 over the fnm deletion
mutant and indicates a role for Fnm in the pathogenesis of infec-
tive endocarditis. With a mixed inoculum containing equal num-
bers of CFU of TX6128 and TX6155, chromosomal reintroduc-
tion of fnm resulted in the restoration of the infective phenotype at
wild-type levels in 40% of the animals (n 5) (data not shown).
Because the Fnm homologue protein of E. faecalis (EfbA) has
been shown to contribute to UTIs in a murine model (25), we
tested whether Fnm plays a role in the pathogenicity of UTIs
caused by E. faecium TX82. Mice were inoculated via an intraure-
thral catheter with a mixture consisting of 53% TX82 cells and
47% TX6128 cells. However, as shown in Fig. S1 in the supple-
mentalmaterial, TX82 andTX6128were recovered at similar rates
frommouse kidneys (P 0.6544) or bladders (P 0.0562), indi-
cating that TX6128 was not attenuated relative to the wild-type
strain.
DISCUSSION
The process of bacterial infection is initiated by the interaction of
microorganisms with components of host tissues. Previous stud-
ies have shown that E. faecium cells express a variety of surface
proteins that can contribute to adhesion (41). These include an
endocarditis- and biofilm-associated pilus protein (Ebpfm) (42),
an enterococcal surface protein (Esp) (43), serine–glutamate re-
peat-containing protein A (SgrA) (44), and the WxL proteins
(26). In addition, we identified a significant association between
collagen adherence and the presence of a functional acm gene,
encoding an adhesin of collagen, in clinical but not community
isolates (45, 46). Furthermore, Acmwas found to be important in
the pathogenesis of infective endocarditis (47). A report on the
adherence of E. faecium to Fn demonstrated a greater ability of
clinical isolates, especially endocarditis-derived nosocomial iso-
lates, than of nonclinical isolates to bind to Fn (48). Also, in other
Gram-positive bacteria, the presence of Fn-binding proteins on
the surfacewas shown to play a critical role in the infection process
(49). Thus, it is possible that interactions with Fn favor the initi-
ation and establishment of E. faecium infections.
In the present study, homology-driven mining of the ge-
nome of E. faecium TX82 identified fnm, encoding a protein that
exhibits considerable identity to the anchorless, but surface-ex-
posed, fibronectin-binding PavA protein of S. pneumoniae. Like
PavA, Fnm is an atypical Fn-binding protein in that it lacks a
secretory sequence, identifiable Fn-binding repeats, and a conven-
tional LPXTGanchoringmotif (Fig. 1). Fnm shares high similarity
with PavA and other homologous proteins found in streptococci
and in E. faecalis (Fig. 2), suggesting a conserved function, which
FIG 5 Binding of E. faecium TX82, TX6128, and TX6155 cells to fibronectin.
Fibronectin (20 g/well) was immobilized on a microtiter plate, and BHIS-
grown E. faeciumTX82, TX6128, and TX6155 cells were added to the wells and
were allowed to adhere for 2 h. Adherent bacteria were detected by crystal
violet staining. Experiments were performed three times each with eight tech-
nical replicates. Values are means	 standard deviations. *, P 0.05; ns, not
significant. The binding of TX6128 and TX6155 to fibronectin was expressed
relative to the adherence ability of E. faecium TX82 (defined as 100%).
FIG 6 Western blot of cell wall-associated protein extracts. E. faecium strains
were grown for 5 h (log phase) or 16 h (stationary phase) in BHI broth with or
without 40% horse serum. CWA proteins were extracted by mutanolysin di-
gestion and were immunoblotted with antibody against the rFnm protein.
Only the sample collected from cells grown in BHIS for 16 h is shown for the
deletion mutant TX6128, because all others were negative.
FIG 7 Attenuation of a nonpolar fnm deletion mutant in a mixed-inoculum
infection model of rat endocarditis. Rats were sacrificed at 48 h postinfection,
and bacteria were recovered from vegetations. Horizontal lines indicate mean
percentages (P 0.0001 by a paired t test) of bacteria in the aortic valves or in
the inoculum.
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might be different from its role as an adhesin. All the PavA homo-
logues contain a large N-terminal domain annotated as an Fn-
binding domain (“FbpA”) followed by a C-terminal Duf814 do-
main. While Duf814 has yet to be characterized, it has often been
reported in association with the FbpA domain, in archeal and
eukaryotic as well as prokaryotic adhesins (11). Since all the
PavA homologues lack conventional secretory and anchorage se-
quences, the existence of a novel, yet to be determinedmechanism
of secretion and cell surface association has been postulated (14).
Bacterial cell surface association, despite the absence of a putative
signal sequence and a cell wall anchor motif, has also been exhib-
ited by other virulence-associated proteins, such as the streptococ-
cal surface dehydrogenase, the surface enolase of S. pyogenes, and
the pneumococcal -enolase (50–52). It is also possible that this
protein has another function, perhaps intracellular, and that the
adherence phenotype is a “moonlighting” function, as suggested
for Gnd (50–53).
In our work here, we found that full-length recombinant Fnm
binds to Fn in a concentration-dependent manner and also binds
to other host ECM proteins, such as laminin and collagen V (Fig.
3). Previous reports on S. pneumoniaePavAdemonstrated that the
C-terminal 189 residues were essential for the binding of protein
to Fn (14). However, Courtney et al. showed that the N-terminal
region of FBP54 is responsible for themajority of the binding of S.
pyogenes to Fn (39). For E. faecium Fnm, wemapped the principal
Fn-binding domain to the N-terminal half of the protein. How-
ever, there was modest binding of Fnm416–535 to immobilized Fn,
suggesting that the C-terminal Duf814 domain could mediate a
reduced level of adherence (Fig. 4).
The ability of bacteria to sense and finely regulate the produc-
tion of virulence factors is important in their transition from col-
onizers to pathogens and for avoidance of the host immune de-
fense (54). Several enterococcal adhesins have been shown to be
conditionally expressed in response to environmental stresses, in-
cluding growth at 46°C or the presence of serum (34, 55). A study
that examined the adherence phenotypes of diverse E. faecalis
strains to ECM proteins after in vitro growth under conditions
mimicking physiological conditions demonstrated that serum
promotes enterococcal binding to Fn (40). In keeping with these
data, we showed that Fnm is found in cell wall extracts of E. fae-
cium TX82 grown in BHI medium supplemented with 40% horse
serum but not in extracts of TX82 grown in BHI medium only
(Fig. 6). These results suggest that Fnm is not constitutively ex-
pressed by E. faecium but is elicited under certain conditions,
where serum may serve as a signal to induce the production of
Fnm on the cell surface (40). Inactivation of fnm was associated
with a significant reduction (P  0.001) in the binding of E. fae-
cium TX82 to fibronectin (Fig. 5), in accordance with the absence
of this adhesin from the cell surface. It would be of interest to
examine human sera for the presence of antibodies against Fnm in
order to provide evidence of in vivo expression in humans.
Infective endocarditis, a disease that involves bacterial infec-
tion of heart valves and/or the inner surface of the heart chamber
(endothelium), is often initiated by damage to the endothelium
that disrupts the integrity of the aortic valves and exposes under-
lying tissues and ECM, including Fn (56). Enterococcimay adhere
directly to the site of damage or to sterile thrombotic vegetations,
consisting of fibrin and platelets, leading to infected vegetations.
Because enterococci are the third most common etiological cause
of this disease (57), we hypothesized that Fnm could play a role in
the formation of E. faecium vegetations on the aortic valves. Dele-
tion of fnm from the genome of E. faecium TX82 resulted in sig-
nificant attenuation of the ability of the isogenic mutant, TX6128,
to compete with the wild type in the infection of catheter-induced
vegetations, demonstrating that Fnm is an important factor in the
experimental model of endocarditis caused by E. faecium. The
reintroduction of fnm into its original chromosomal location re-
sulted in a fully restored wild-type phenotype in 40% of the in-
fected animals (data not shown); the genetic basis for the lack of
restoration of Fnm function in all animals is under investigation
in our laboratory. Interestingly, we have observed a similar “bi-
modal” pattern, with one or two animals showing the reverse of
the results for the others, with several other enterococcal mutants
tested previously (35, 47, 58).
In a recent investigation by Torelli et al., the Fnm homologue
protein of E. faecalis JH2-2 (EfbA) was shown to contribute to
pathogenesis in a murine model of ascending urinary tract infec-
tion, a finding consistent with an increased trophism for the kid-
neys and bladder (25). Interestingly, fnm deletion did not result in
observable effects in the kidneys in a similar UTI model, suggest-
ing that E. faecium Fnm does not contribute to this infection (see
Fig. S1 in the supplemental material).
In summary, our study reports the identification and partial
characterization of Fnm, an Fn-binding protein of E. faecium be-
longing to the PavA-like class of adhesins. We demonstrated that
Fnm plays a key role in the binding of E. faecium to Fn and to a
wide range of ECMmolecules. Deletion of fnm diminished in vitro
adherence to immobilized Fn and fibrinogen and resulted in sig-
nificant attenuation of the ability of E. faecium TX82 to cause
infective endocarditis in vivo in a rat model. Taking these findings
together, our report contributes to the understanding of the fun-
damentals of interaction between E. faecium and its host.
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